Cyclacel Pharmaceuticals GAAP EPS of -$0.98
Source: SeekingAlpha
2025-08-13 16:31:34 ET
More on Cyclacel Pharmaceuticals
- Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split
- Financial information for Cyclacel Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Cyclacel Pharmaceuticals GAAP EPS of -$0.98
Cyclacel Pharmaceuticals Inc.
NASDAQ: CYCC
CYCC Trading
-22.25% G/L:
$6.3056 Last:
136,780 Volume:
$6.76 Open:
CYCC Latest News
September 12, 2025 06:00:00 am
Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.
August 13, 2025 04:05:00 pm
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
August 05, 2025 07:41:28 am
Plogosertib Shows Promise in Biliary Tract Cancer with BUBR1 as Potential Biomarker
CYCC Stock Data
$14,251,133
1,092,624
60.3%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Kuala Lumpur
